New cholesterol drug showdown: could obicetrapib beat bempedoic acid?
Disease control
Recruiting now
This study tests a new drug called obicetrapib against another drug, bempedoic acid, to see which lowers 'bad' cholesterol more effectively. It involves 426 adults with high cholesterol who are already on maximum cholesterol medications and are at high risk for heart problems. Th…
Phase: PHASE3 • Sponsor: A. Menarini International Licensing S.A. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC